Financhill
Sell
11

MIST Quote, Financials, Valuation and Earnings

Last price:
$1.72
Seasonality move :
-28.56%
Day range:
$1.77 - $1.86
52-week range:
$0.63 - $3.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.56x
Volume:
1.3M
Avg. volume:
2.8M
1-year change:
-16.9%
Market cap:
$155M
Revenue:
--
EPS (TTM):
-$0.86

Earnings Data

Next earnings date for MIST
Mar 12
2026
Most recent earnings per share
-$0.12
Beat by $0.04
(Nov 12/2025)
Consensus Estimate
-$0.17
(Nov 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MIST Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $37.5M -- -- $0.17 --
03/12/2026 Q4 -- -- -- -$0.18 --
11/12/2025 Q3 -- -- -$0.12 -$0.17 $0.04
08/12/2025 Q2 -- -- -$0.20 -$0.18 -$0.02
05/12/2025 Q1 -- -- -$0.31 -$0.20 -$0.12
03/13/2025 Q4 -- -- -$0.23 -$0.15 -$0.08
11/12/2024 Q3 -- -- -$0.14 -$0.18 $0.04
08/08/2024 Q2 -- -- -$0.14 -$0.20 $0.06
05/13/2024 Q1 -- -- -$0.21 -$0.27 $0.06
03/21/2024 Q4 -- -- -$0.32 -$0.33 $0.01
11/13/2023 Q3 -- -- -$0.35 -$0.39 $0.04
08/10/2023 Q2 -- -- -$0.37 -$0.39 $0.02
05/11/2023 Q1 -- -- -$0.35 -$0.40 $0.05
03/29/2023 Q4 -- -- -$0.31 -$0.31 --
11/10/2022 Q3 -- -- -$0.34 -$0.42 $0.08
08/10/2022 Q2 -- -- -$0.39 -$0.37 -$0.02
05/12/2022 Q1 -- -- -$0.33 -$0.38 $0.05
03/24/2022 Q4 -- -- -$0.40 -$0.36 -$0.04
11/12/2021 Q3 -- -- -$0.34 -$0.35 $0.01
08/11/2021 Q2 -- -- $0.02 -$0.35 $0.37
05/17/2021 Q1 -- -- -$0.30 -$0.33 $0.03
03/29/2021 Q4 -- -- -$0.13 -$0.42 $0.29
11/13/2020 Q3 -- -- -$0.40 -$0.46 $0.06
08/12/2020 Q2 -- -- -$0.53 -$0.43 -$0.10
05/14/2020 Q1 -- -- -$0.67 -$0.74 $0.07
03/06/2020 Q4 -- -- -$0.75 -$0.59 -$0.16
11/13/2019 Q3 -- -- -$0.52 -$0.55 $0.03
08/13/2019 Q2 -- -- -$0.56 -$0.56 $0.00

Milestone Pharmaceuticals, Inc. Earnings Questions

  • How Much did Milestone Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Milestone Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Milestone Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Milestone Pharmaceuticals, Inc. announced earnings per share of -$0.12 which represents a beat of analyst forecast a -$0.17 per share.

  • Is Milestone Pharmaceuticals, Inc. Profitable?

    Milestone Pharmaceuticals, Inc. reported -$25K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Milestone Pharmaceuticals, Inc. EPS Next Year?

    Milestone Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$0.67 per share to -$0.71 per share next year representing a decrease of -10.6%.

  • When is Milestone Pharmaceuticals, Inc.'s Earnings Date?

    Milestone Pharmaceuticals, Inc.'s next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
40
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
91
TDC alert for Feb 12

Teradata Corp. [TDC] is down 11.64% over the past day.

Buy
67
DIOD alert for Feb 12

Diodes, Inc. [DIOD] is down 7.63% over the past day.

Buy
77
VRT alert for Feb 12

Vertiv Holdings Co. [VRT] is down 4.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock